Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy.

Saved in:
Bibliographic Details
Title: Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy.
Authors: Fantini M; Precision Biologics, Inc., Bethesda, MD, United States., Arlen PM; Precision Biologics, Inc., Bethesda, MD, United States., Tsang KY; Precision Biologics, Inc., Bethesda, MD, United States.
Source: Frontiers in immunology [Front Immunol] 2023 Nov 24; Vol. 14, pp. 1275904. Date of Electronic Publication: 2023 Nov 24 (Print Publication: 2023).
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2023.1275904